Search for Clinical Trial Results

Sponsored By

Hypereosinophilic Syndrome - 25 Studies Found

Status Study
Terminated Study Name: A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2005-09-13
Interventions: Drug: imatinib mesylate Other Name: Gleevec/Glivec
Completed Study Name: Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2001-06-15
Interventions: Drug: SCH55700
Terminated Study Name: Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2004-11-22
Interventions: Drug: mepolizumab Study Drug
Recruiting Study Name: Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Condition: Hypereosinophilic Syndrome
Date: 2016-07-14
Interventions:
  • Drug: Mepolizumab 300 mg Mepol
Recruiting Study Name: Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2002-08-24
Interventions: Drug: Imatinib Mesylate Imatinib is a tyrosine kinase inhibitor that selectively inhibits bcr-abl, c-kit
Active, not recruiting Study Name: Identification of New Markers in the Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2012-10-22
Interventions: Biological: biologie sample comparison of biomarkers between HES, HE biomarkers data and control arms
Active, not recruiting Study Name: Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2014-03-14
Interventions: Drug: Dexpramipexole Dexpramipexole (KNS 760704) is a synthetic amino-benzothiazole developed for use in
Recruiting Study Name: Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Date: 2014-04-03
Interventions:
  • Drug: benralizumab An afucosyl
Completed Study Name: Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Condition:
  • Hypereosinophilia
  • Hypereosinophilic Syndrome

Date: 2004-07-07
Interventions: Drug: mepolizumab
Withdrawn Study Name: Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
Condition:
  • Eosinophilia
  • Hypereosinophilic Syndrome

Date: 2005-09-28
Interventions: Drug: Gleevec
Next >>>